Skip to main content
. 2013 Feb 28;5(5):1731–1735. doi: 10.3892/ol.2013.1215

Table III.

Association of VDR FokI and BsmI polymorphisms and PC risk.

Group
Genotype PC, n (%) Control, n (%) OR 95% CI P-value
FokIa
  FF (CC) 22 (24.2) 37 (46.3) 1
  Ff (CT) 46 (50.5) 31 (38.7) 2.496 1.243–5.011 0.009
  ff (TT) 23 (25.3) 12 (15.0) 3.223 1.344–7.733 0.008
  Ff+ff 69 43 2.699 1.408–5.173 0.002
  FF 22 37
  FF+Ff 68 43
  F 90 (49.5) 105 (65.6) 1
  f 92 (50.5) 55 (34.4) 1.952 1.261–3.021 0.003
BsmIb
  BB (AA) 23 (25.3) 26 (32.5) 1
  Bb (AG) 40 (44.0) 41 (51.2) 1.103 0.542–2.244 0.787
  bb (GG) 28 (30.7) 13 (16.3) 2.435 1.026–5.780 0.042
  Bb+bb 68 54 1.424 0.732–2.768 0.297
  BB 23 26
  Bb+bb 68 54
  B 86 (47.3) 93 (58.1) 1
  b 96 (52.7) 67 (41.9) 0.645 0.421–0.990 0.045

VDR, vitamin D receptor; PC, pancreatic cancer; OR, odds ratio; CI, confidence interval.

a

Ptrend=0.009;

b

Ptrend=0.0082.